首页> 外文期刊>World Journal of Gastroenterology >Early detection of response to imatinib therapy for gastrointestinal stromal tumor by using 18F-FDG-positron emission tomography and computed tomography imaging
【24h】

Early detection of response to imatinib therapy for gastrointestinal stromal tumor by using 18F-FDG-positron emission tomography and computed tomography imaging

机译:18F-FDG-正电子发射断层显像和计算机断层显像技术早期发现对伊马替尼治疗胃肠道间质瘤的反应

获取原文
获取原文并翻译 | 示例
           

摘要

A 41-year old female with metastatic gastrointestinal stromal tumor was referred to 18F-FDG-positron emission tomography and computed tomography (PET/CT) scan before and after one-month treatment with imatinib (Glivec~®, Gleevec~®, Novartis, Basel, Switzerland), a tyrosine kinase inhibitor (400 mg/d). Metabolic response was evaluated before and after one month of therapy. The decrease of the maximum standardised uptake value (SUV) was 79% (from 9.8 to 2.1). Positron emission tomography demonstrated complete metabolic response after one-month of imatinib treatment. Additionally, the previous lesion was compared with the coronal computerized tomographic image. There was no difference in the size of the tumor before and after therapy according to CT images. However, metabolic activity was inhibited. 18F-FDG-PET is a valuable method for the detection of response to one-month imatinib treatment in patients with gastrointestinal stromal tumors.
机译:一名41岁转移性胃肠道间质瘤女性在接受伊马替尼(Glivec®,Gleevec〜®,诺华,瑞士巴塞尔),一种酪氨酸激酶抑制剂(400 mg / d)。在治疗一个月之前和之后评估代谢反应。最大标准摄取值(SUV)降低了79%(从9.8降低到2.1)。伊马替尼治疗一个月后,正电子发射断层扫描显示完全的代谢反应。此外,将先前的病变与冠状计算机断层扫描图像进行了比较。根据CT图像,治疗前后的肿瘤大小无差异。但是,代谢活性受到抑制。 18F-FDG-PET是一种用于检测胃肠道间质瘤患者对伊马替尼治疗一个月的反应的有价值的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号